SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-016648
Filing Date
2019-05-08
Accepted
2019-05-07 17:41:49
Documents
54
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q gwph-10q_20190331.htm 10-Q 1193295
2 EX-10.1 gwph-ex101_76.htm EX-10.1 250976
3 EX-31.1 gwph-ex311_111.htm EX-31.1 11515
4 EX-31.2 gwph-ex312_110.htm EX-31.2 11444
5 EX-32.1 gwph-ex321_112.htm EX-32.1 6482
6 EX-32.2 gwph-ex322_113.htm EX-32.2 6574
  Complete submission text file 0001564590-19-016648.txt   4239240

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT gwph-20190331.xml EX-101.INS 755332
8 XBRL TAXONOMY EXTENSION SCHEMA gwph-20190331.xsd EX-101.SCH 33059
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gwph-20190331_cal.xml EX-101.CAL 60496
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gwph-20190331_def.xml EX-101.DEF 48036
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE gwph-20190331_lab.xml EX-101.LAB 248611
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gwph-20190331_pre.xml EX-101.PRE 177179
Mailing Address SOVEREIGN HOUSE VISION PARK HISTON, CAMBRIDGE CB24 9BZ X0 00000
Business Address SOVEREIGN HOUSE VISION PARK HISTON, CAMBRIDGE CB24 9BZ X0 00000 44 1223 266800
GW PHARMACEUTICALS PLC (Filer) CIK: 0001351288 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-35892 | Film No.: 19804376
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1